{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:15:55Z","timestamp":1790252155290,"version":"4.1.0"},"reference-count":97,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T00:00:00Z","timestamp":1568073600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Vaccination has had great success in combating diseases, especially infectious diseases. However, traditional vaccination strategies are ineffective for several life-threatening diseases, including acquired immunodeficiency syndrome (AIDS), tuberculosis, malaria, and cancer. Viral vaccine vectors represent a promising strategy because they can efficiently deliver foreign genes and enhance antigen presentation in vivo. However, several limitations, including pre-existing immunity and packaging capacity, block the application of viral vectors. Cytomegalovirus (CMV) has been demonstrated as a new type of viral vector with additional advantages. CMV could systematically elicit and maintain high frequencies of effector memory T cells through the \u201cmemory inflation\u201d mechanism. Studies have shown that CMV can be genetically modified to induce distinct patterns of CD8+ T-cell responses, while some unconventional CD8+ T-cell responses are rarely induced through conventional vaccine strategies. CMV has been used as a vaccine vector to deliver many disease-specific antigens, and the efficacy of these vaccines was tested in different animal models. Promising results demonstrated that the robust and unconventional T-cell responses elicited by the CMV-based vaccine vector are essential to control these diseases. These accumulated data and evidence strongly suggest that a CMV-based vaccine vector represents a promising approach to develop novel prophylactic and therapeutic vaccines against some epidemic pathogens and tumors.<\/jats:p>","DOI":"10.3390\/ijms20184457","type":"journal-article","created":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T10:52:26Z","timestamp":1568112746000},"page":"4457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Promising Cytomegalovirus-Based Vaccine Vector Induces Robust CD8+ T-Cell Response"],"prefix":"10.3390","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3622-2767","authenticated-orcid":false,"given":"Jian","family":"Liu","sequence":"first","affiliation":[{"name":"School of Biological Sciences and Biotechnology, Minnan Normal University, Zhangzhou 363000, China"},{"name":"College of Life Sciences, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabbu Kumar","family":"Jaijyan","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers\u2014New Jersey Medical School, Newark, NJ 07103, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6487-2356","authenticated-orcid":false,"given":"Qiyi","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Howard University College of Medicine, Washington, DC 20059, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6087-3175","authenticated-orcid":false,"given":"Hua","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers\u2014New Jersey Medical School, Newark, NJ 07103, USA"},{"name":"College of Life Sciences, Jinan University, Guangzhou 510632, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e2034","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med Virol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the united states, 1988\u20131994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: A review","volume":"45","author":"Ramanan","year":"2013","journal-title":"Infect. Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev. Med Virol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1086\/421999","article-title":"Vaccine development to prevent cytomegalovirus disease: Report from the national vaccine advisory committee","volume":"39","author":"Arvin","year":"2004","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e00268-17","DOI":"10.1128\/CVI.00268-17","article-title":"Progress toward development of a vaccine against congenital cytomegalovirus infection","volume":"24","author":"Schleiss","year":"2017","journal-title":"Clin. Vaccine Immunol. CVI"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1158\/2326-6066.CIR-14-0044","article-title":"Cytomegalovirus-based vaccine expressing a modified tumor antigen induces potent tumor-specific cd8(+) t-cell response and protects mice from melanoma","volume":"3","author":"Qiu","year":"2015","journal-title":"Cancer Immunol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"14223","DOI":"10.1073\/pnas.2334032100","article-title":"Functional profiling of a human cytomegalovirus genome","volume":"100","author":"Dunn","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1128\/JVI.75.4.1870-1878.2001","article-title":"Human cytomegalovirus with ie-2 (ul122) deleted fails to express early lytic genes","volume":"75","author":"Marchini","year":"2001","journal-title":"J. Virol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/jmv.24484","article-title":"Functional analysis of human cytomegalovirus ul\/b\u2019 region using scid-hu mouse model","volume":"88","author":"Dulal","year":"2016","journal-title":"J. Med Virol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1056\/NEJM200105033441804","article-title":"Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity","volume":"344","author":"Boppana","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0140-6736(74)92997-3","article-title":"Development of a vaccine against mental retardation caused by cytomegalovirus infection in utero","volume":"1","author":"Elek","year":"1974","journal-title":"Lancet"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1128\/iai.12.3.521-527.1975","article-title":"Candidate cytomegalovirus strain for human vaccination","volume":"12","author":"Plotkin","year":"1975","journal-title":"Infect. Immun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.3181\/00379727-160-40382","article-title":"Clinical and laboratory studies of live cytomegalovirus vaccine ad-169","volume":"160","author":"Neff","year":"1979","journal-title":"Proc. Soc. Exp. Biol Med."},{"key":"ref_16","first-page":"1176","article-title":"Multicenter trial of towne strain attenuated virus vaccine in seronegative renal transplant recipients","volume":"58","author":"Plotkin","year":"1994","journal-title":"Transplantation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/infdis\/171.1.26","article-title":"Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age","volume":"171","author":"Adler","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/infdis\/jiw365","article-title":"A phase 1 study of 4 live, recombinant human cytomegalovirus towne\/toledo chimera vaccines in cytomegalovirus-seronegative men","volume":"214","author":"Adler","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1086\/503365","article-title":"A phase 1 study of 4 live, recombinant human cytomegalovirus towne\/toledo chimeric vaccines","volume":"193","author":"Heineman","year":"2006","journal-title":"J. Infect. Dis."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"428498","DOI":"10.1155\/2012\/428498","article-title":"Bacterial artificial chromosome clones of viruses comprising the towne cytomegalovirus vaccine","volume":"2012","author":"Cui","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1128\/JVI.00320-16","article-title":"Repair of a mutation disrupting the guinea pig cytomegalovirus pentameric complex acquired during fibroblast passage restores pathogenesis in immune-suppressed guinea pigs and in the context of congenital infection","volume":"90","author":"McVoy","year":"2016","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"10330","DOI":"10.1128\/JVI.79.16.10330-10338.2005","article-title":"Human cytomegalovirus ul131 open reading frame is required for epithelial cell tropism","volume":"79","author":"Wang","year":"2005","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362ra145","DOI":"10.1126\/scitranslmed.aaf9387","article-title":"A replication-defective human cytomegalovirus vaccine for prevention of congenital infection","volume":"8","author":"Wang","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2008.07.092","article-title":"Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection","volume":"26","author":"Cui","year":"2008","journal-title":"Vaccine"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1074\/jbc.M115.652230","article-title":"Soluble human cytomegalovirus gh\/gl\/pul128-131 pentameric complex, but not gh\/gl, inhibits viral entry to epithelial cells and presents dominant native neutralizing epitopes","volume":"290","author":"Loughney","year":"2015","journal-title":"J. Biol. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Lilleri, D., Kabanova, A., Revello, M.G., Percivalle, E., Sarasini, A., Genini, E., Sallusto, F., Lanzavecchia, A., Corti, D., and Gerna, G. (2013). Fetal human cytomegalovirus transmission correlates with delayed maternal antibodies to gh\/gl\/pul128-130-131 complex during primary infection. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0059863"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"7469","DOI":"10.1016\/j.vaccine.2012.10.053","article-title":"Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus","volume":"30","author":"Fu","year":"2012","journal-title":"Vaccine"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.cell.2006.07.025","article-title":"A rapid, reversible, and tunable method to regulate protein function in living cells using synthetic small molecules","volume":"126","author":"Banaszynski","year":"2006","journal-title":"Cell"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e11911","DOI":"10.7554\/eLife.11911","article-title":"Human cytomegalovirus ie1 protein alters the higher-order chromatin structure by targeting the acidic patch of the nucleosome","volume":"5","author":"Fang","year":"2016","journal-title":"eLife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.4049\/jimmunol.1502527","article-title":"Distinct roles for human cytomegalovirus immediate early proteins ie1 and ie2 in the transcriptional regulation of mica and pvr\/cd155 expression","volume":"197","author":"Pignoloni","year":"2016","journal-title":"J. Immunol"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1128\/JVI.02606-13","article-title":"Human cytomegalovirus major immediate early 1 protein targets host chromosomes by docking to the acidic pocket on the nucleosome surface","volume":"88","author":"Mucke","year":"2014","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1128\/JVI.01955-12","article-title":"The human cytomegalovirus ul51 protein is essential for viral genome cleavage-packaging and interacts with the terminase subunits pul56 and pul89","volume":"87","author":"Borst","year":"2013","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"S308","DOI":"10.1093\/ofid\/ofx163.718","article-title":"Phase 1 clinical trial of a replication-defective human cytomegalovirus (cmv) vaccine","volume":"4","author":"Adler","year":"2017","journal-title":"Open Forum Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/COH.0000000000000524","article-title":"Human cytomegalovirus-vectored vaccines against hiv","volume":"14","author":"Goonetilleke","year":"2019","journal-title":"Curr. Opin. HIV AIDS"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1080\/21645515.2016.1276138","article-title":"Progress in hiv vaccine development","volume":"13","author":"Hsu","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14712598.2017.1282457","article-title":"Current views on the potential for development of a hiv vaccine","volume":"17","author":"Cohen","year":"2017","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1086\/428404","article-title":"Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent hiv-1 infection","volume":"191","author":"Flynn","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(08)61591-3","article-title":"Efficacy assessment of a cell-mediated immunity hiv-1 vaccine (the step study): A double-blind, randomised, placebo-controlled, test-of-concept trial","volume":"372","author":"Buchbinder","year":"2008","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1086\/587993","article-title":"Safety and immunogenicity of a replication-incompetent adenovirus type 5 hiv-1 clade b gag\/pol\/nef vaccine in healthy adults","volume":"46","author":"Priddy","year":"2008","journal-title":"Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1310566","article-title":"Efficacy trial of a DNA\/rad5 hiv-1 preventive vaccine","volume":"369","author":"Hammer","year":"2013","journal-title":"New Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/ni.3647","article-title":"Hiv-1 blocks the signaling adaptor mavs to evade antiviral host defense after sensing of abortive hiv-1 rna by the host helicase ddx3","volume":"18","author":"Gringhuis","year":"2017","journal-title":"Nat. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nm.4100","article-title":"Impact of pre-adapted hiv transmission","volume":"22","author":"Carlson","year":"2016","journal-title":"Nat. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature08757","article-title":"Targeting early infection to prevent hiv-1 mucosal transmission","volume":"464","author":"Haase","year":"2010","journal-title":"Nature"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic siv by an effector memory t-cell vaccine","volume":"473","author":"Hansen","year":"2011","journal-title":"Nature"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic siv infection","volume":"502","author":"Hansen","year":"2013","journal-title":"Nature"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","article-title":"Effector memory t cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge","volume":"15","author":"Hansen","year":"2009","journal-title":"Nat. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.immuni.2016.09.015","article-title":"Antiviral cd8(+) t cells restricted by human leukocyte antigen class ii exist during natural hiv infection and exhibit clonal expansion","volume":"45","author":"Ranasinghe","year":"2016","journal-title":"Immunity"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2695396","DOI":"10.1155\/2016\/2695396","article-title":"Characteristics of hla-e restricted t-cell responses and their role in infectious diseases","volume":"2016","author":"Joosten","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate cd8+ t cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"key":"ref_50","first-page":"37","article-title":"The hcmv gene products us2 and us11 target mhc class i molecules for degradation in the cytosol","volume":"269","author":"Kikkert","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/imr.12428","article-title":"The comings and goings of mhc class i molecules herald a new dawn in cross-presentation","volume":"272","author":"Blander","year":"2016","journal-title":"Immunol. Rev."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1128\/JVI.79.9.5786-5798.2005","article-title":"Rhesus cytomegalovirus contains functional homologues of us2, us3, us6, and us11","volume":"79","author":"Pande","year":"2005","journal-title":"J. Virol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"e01650-16","DOI":"10.1128\/JVI.01650-16","article-title":"Impact of antibodies and strain polymorphisms on cytomegalovirus entry and spread in fibroblasts and epithelial cells","volume":"91","author":"Cui","year":"2017","journal-title":"J. Virol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1126\/science.aac9475","article-title":"Broadly targeted cd8(+) t cell responses restricted by major histocompatibility complex e","volume":"351","author":"Hansen","year":"2016","journal-title":"Science"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coi.2017.06.010","article-title":"Cd8+ t cell programming by cytomegalovirus vectors: Applications in prophylactic and therapeutic vaccination","volume":"47","author":"Fruh","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.cell.2014.11.024","article-title":"Host evasion and exploitation schemes of mycobacterium tuberculosis","volume":"159","author":"Cambier","year":"2014","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/ni.3048","article-title":"The balance between protective and pathogenic immune responses in the tb-infected lung","volume":"16","author":"Orme","year":"2015","journal-title":"Nat. Immunol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of bcg vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: A meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1128\/MMBR.00021-14","article-title":"Tuberculosis vaccines and prevention of infection","volume":"78","author":"Hawn","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.4049\/jimmunol.1302523","article-title":"A novel murine cytomegalovirus vaccine vector protects against mycobacterium tuberculosis","volume":"193","author":"Beverley","year":"2014","journal-title":"J. Immunol"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nm.4473","article-title":"Prevention of tuberculosis in rhesus macaques by a cytomegalovirus-based vaccine","volume":"24","author":"Hansen","year":"2018","journal-title":"Nat. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nri.2016.80","article-title":"Regulatory circuits of t cell function in cancer","volume":"16","author":"Speiser","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/onc.2009.416","article-title":"Immune infiltration in human tumors: A prognostic factor that should not be ignored","volume":"29","author":"Pages","year":"2010","journal-title":"Oncogene"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/978-1-62703-727-3_16","article-title":"Tumor-infiltrating lymphocytes and their significance in melanoma prognosis","volume":"1102","author":"Schatton","year":"2014","journal-title":"Methods Mol. Biol"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e27668","DOI":"10.4161\/onci.27668","article-title":"Location, location, location: Cd103 demarcates intraepithelial, prognostically favorable cd8(+) tumor-infiltrating lymphocytes in ovarian cancer","volume":"3","author":"Webb","year":"2014","journal-title":"Oncoimmunology"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1084\/jem.20050882","article-title":"Broadly targeted human cytomegalovirus-specific cd4+ and cd8+ t cells dominate the memory compartments of exposed subjects","volume":"202","author":"Sylwester","year":"2005","journal-title":"J. Exp. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/eji.201746964","article-title":"Cytomegalovirus vector expressing rae-1gamma induces enhanced anti-tumor capacity of murine cd8+ t cells","volume":"47","author":"Trsan","year":"2017","journal-title":"Eur. J. Immunol."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Dekhtiarenko, I., Ratts, R.B., Blatnik, R., Lee, L.N., Fischer, S., Borkner, L., Oduro, J.D., Marandu, T.F., Hoppe, S., and Ruzsics, Z. (2016). Peptide processing is critical for t-cell memory inflation and may be optimized to improve immune protection by cmv-based vaccine vectors. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1006072"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbrc.2013.06.068","article-title":"Cytomegalovirus-based cancer vaccines expressing trp2 induce rejection of melanoma in mice","volume":"437","author":"Xu","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1172\/JCI80009","article-title":"Therapeutic cancer vaccines","volume":"125","author":"Melief","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1080\/21645515.2017.1331795","article-title":"Intratumoral infection by cmv may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity","volume":"13","author":"Erkes","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2217\/imt.15.110","article-title":"Cytomegalovirus and immunotherapy: Opportunistic pathogen, novel target for cancer and a promising vaccine vector","volume":"8","author":"Quinn","year":"2016","journal-title":"Immunotherapy"},{"key":"ref_74","first-page":"315","article-title":"Murine model of cytomegalovirus latency and reactivation","volume":"325","author":"Reddehase","year":"2008","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.micinf.2003.09.007","article-title":"Pathogenesis of murine cytomegalovirus infection","volume":"5","author":"Krmpotic","year":"2003","journal-title":"Microbes Infect."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1084\/jem.20161988","article-title":"Fibroblast-adapted human cmv vaccines elicit predominantly conventional cd8 t cell responses in humans","volume":"214","author":"Murray","year":"2017","journal-title":"J. Exp. Med."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1073\/pnas.90.1.104","article-title":"Human cytomegalovirus in a scid-hu mouse: Thymic epithelial cells are prominent targets of viral replication","volume":"90","author":"Mocarski","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/s41598-017-01051-5","article-title":"Human cytomegalovirus induces cellular and humoral virus-specific immune responses in humanized blt mice","volume":"7","author":"Crawford","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1099\/vir.0.81891-0","article-title":"Latency and reactivation of human cytomegalovirus","volume":"87","author":"Sinclair","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-015-1905-z","article-title":"Is cmv a target in pediatric glioblastoma? Expression of cmv proteins, pp65 and ie1-72 and cmv nucleic acids in a cohort of pediatric glioblastoma patients","volume":"125","author":"Wakefield","year":"2015","journal-title":"J. Neuro-Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Herbein, G. (2018). The human cytomegalovirus, from oncomodulation to oncogenesis. Viruses, 10.","DOI":"10.3390\/v10080408"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3389\/fonc.2014.00230","article-title":"The oncogenic potential of human cytomegalovirus and breast cancer","volume":"4","author":"Herbein","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1593\/neo.81178","article-title":"The story of human cytomegalovirus and cancer: Increasing evidence and open questions","volume":"11","author":"Michaelis","year":"2009","journal-title":"Neoplasia"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/ijc.29923","article-title":"Constitutive activation of stat3 in breast cancer cells: A review","volume":"138","author":"Banerjee","year":"2016","journal-title":"Int. J. Cancer"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.cancergencyto.2009.10.004","article-title":"Role of stat3 decoy oligodeoxynucleotides on cell invasion and chemosensitivity in human epithelial ovarian cancer cells","volume":"197","author":"Zhang","year":"2010","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_86","first-page":"e678","article-title":"Human cytomegalovirus interleukin-10 promotes proliferation and migration of mcf-7 breast cancer cells","volume":"2","author":"Bishop","year":"2015","journal-title":"Cancer Cell Microenviron."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1071\/RD9940401","article-title":"The potential of murine cytomegalovirus as a viral vector for immunocontraception","volume":"6","author":"Shellam","year":"1994","journal-title":"Reprod. Fertil. Dev."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1095\/biolreprod.102.012880","article-title":"Immunocontraception is induced in balb\/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3","volume":"68","author":"Lloyd","year":"2003","journal-title":"Biol. Reprod."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/CJI.0b013e3182585d50","article-title":"A cytomegalovirus-based vaccine expressing a single tumor-specific cd8+ t-cell epitope delays tumor growth in a murine model of prostate cancer","volume":"35","author":"Klyushnenkova","year":"2012","journal-title":"J. Immunother"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.vaccine.2015.03.029","article-title":"A cytomegalovirus-based vaccine provides long-lasting protection against lethal ebola virus challenge after a single dose","volume":"33","author":"Tsuda","year":"2015","journal-title":"Vaccine"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Hansen, S.G., Womack, J., Scholz, I., Renner, A., Edgel, K.A., Xu, G., Ford, J.C., Grey, M., St Laurent, B., and Turner, J.M. (2019). Cytomegalovirus vectors expressing plasmodium knowlesi antigens induce immune responses that delay parasitemia upon sporozoite challenge. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0210252"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/mi.2016.48","article-title":"Intranasal administration of rsv antigen-expressing mcmv elicits robust tissue-resident effector and effector memory cd8+ t cells in the lung","volume":"10","author":"Morabito","year":"2017","journal-title":"Mucosal Immunol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Pandey, A., Singh, N., Vemula, S.V., Couetil, L., Katz, J.M., Donis, R., Sambhara, S., and Mittal, S.K. (2012). Impact of preexisting adenovirus vector immunity on immunogenicity and protection conferred with an adenovirus-based h5n1 influenza vaccine. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033428"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7262","DOI":"10.4049\/jimmunol.1000751","article-title":"Preexisting vaccinia virus immunity decreases siv-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA\/mva vaccine","volume":"185","author":"Kannanganat","year":"2010","journal-title":"J. Immunol"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1099\/vir.0.81583-0","article-title":"Mixed infection with multiple strains of murine cytomegalovirus occurs following simultaneous or sequential infection of immunocompetent mice","volume":"87","author":"Gorman","year":"2006","journal-title":"J. Gen. Virol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jaut.2010.03.002","article-title":"Immunoglobulin to zona pellucida 3 mediates ovarian damage and infertility after contraceptive vaccination in mice","volume":"35","author":"Lloyd","year":"2010","journal-title":"J. Autoimmun."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/CJI.0b013e318247642f","article-title":"Generation of polyclonal cmv-specific t cells for the adoptive immunotherapy of glioblastoma","volume":"35","author":"Ghazi","year":"2012","journal-title":"J. Immunother"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4457\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:18:26Z","timestamp":1760188706000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/18\/4457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,10]]},"references-count":97,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2019,9]]}},"alternative-id":["ijms20184457"],"URL":"https:\/\/doi.org\/10.3390\/ijms20184457","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,10]]}}}